HOUSE BILL NO. 103
View Daily Data Tracking History
View Bill Text
View Statement of Purpose / Fiscal Impact
Text to be added within a bill has been marked with Bold and
Underline. Text to be removed has been marked with
Strikethrough and Italic. How these codes are actually displayed will
vary based on the browser software you are using.
This sentence is marked with bold and underline to show added text.
This sentence is marked with strikethrough and italic, indicating
text to be removed.
H0103.................................................by HEALTH AND WELFARE
CONTROLLED SUBSTANCES - Amends existing law to add the drug carisoprodol to
schedule IV controlled substances.
01/29 House intro - 1st rdg - to printing
01/30 Rpt prt - to Health/Wel
|||| LEGISLATURE OF THE STATE OF IDAHO ||||
Fifty-sixth Legislature First Regular Session - 2001
IN THE HOUSE OF REPRESENTATIVES
HOUSE BILL NO. 103
BY HEALTH AND WELFARE COMMITTEE
1 AN ACT
2 RELATING TO CONTROLLED SUBSTANCES; AMENDING SECTION 37-2711, IDAHO CODE, TO
3 ADD THE DRUG CARISOPRODOL TO SCHEDULE IV CONTROLLED SUBSTANCES.
4 Be It Enacted by the Legislature of the State of Idaho:
5 SECTION 1. That Section 37-2711, Idaho Code, be, and the same is hereby
6 amended to read as follows:
7 37-2711. SCHEDULE IV. (a) Schedule IV shall consist of the drugs and
8 other substances, by whatever official name, common or usual name, chemical
9 name, or brand name designated, listed in this section.
10 (b) Narcotic drugs. Unless specifically excepted or unless listed in
11 another schedule, any material, compound, mixture, or preparation containing
12 any of the following narcotic drugs, or their salts calculated as the free
13 anhydrous base or alkaloid, in limited quantities as set forth below:
14 (1) No more than 1 milligram of difenoxin and not less than 25 micrograms
15 of atropine sulfate per dosage unit;
16 (2) Dextropropoxyphene (alpha-(+)-4-dimethylamino-1,
17 2-diphenyl-3-methyl-2-propionoxybutane).
18 (c) Depressants. Unless specifically excepted or unless listed in another
19 schedule, any material, compound, mixture, or preparation which contains any
20 quantity of the following substances, including its salts, isomers, and salts
21 of isomers whenever the existence of such salts, isomers, and salts of isomers
22 is possible within the specific chemical designation:
23 (1) Alprazolam;
24 (2) Barbital;
25 (3) Bromazepam;
26 (4) Camazepam;
27 (5) Chloral betaine;
28 (6) Chloral hydrate;
29 (7) Chlordiazepoxide;
30 (8) Clobazam;
31 (9) Clonazepam;
32 (10) Clorazepate;
33 (11) Clotiazepam;
34 (12) Cloxazolam;
35 (13) Delorazepam;
36 (14) Diazepam;
37 (15) Estazolam;
38 (16) Ethchlorvynol;
39 (17) Ethinamate;
40 (18) Ethyl loflazepate;
41 (19) Fludiazepam;
42 (20) Flurazepam;
43 (21) Halazepam;
2
1 (22) Haloxazolam;
2 (23) Ketazolam;
3 (24) Loprazolam;
4 (25) Lorazepam;
5 (26) Lormetazepam;
6 (27) Mebutamate;
7 (28) Medazepam;
8 (29) Meprobamate;
9 (30) Methohexital;
10 (31) Methylphenobarbital (mephobarbital);
11 (32) Midazolam;
12 (33) Nimetazepam;
13 (34) Nitrazepam;
14 (35) Nordiazepam;
15 (36) Oxazepam;
16 (37) Oxazolam;
17 (38) Paraldehyde;
18 (39) Petrichloral;
19 (40) Phenobarbital;
20 (41) Pinazepam;
21 (42) Prazepam;
22 (43) Temazepam;
23 (44) Tetrazepam;
24 (45) Triazolam;
25 (46) Quazepam;
26 (47) Zolpidem.
27 (d) Fenfluramine - Any material, compound, mixture, or preparation which
28 contains any quantity of the following substances, including its salts,
29 isomers (whether optical, position, or geometric), and salts of such isomers,
30 whenever the existence of such salts, isomers, and salts of isomers is possi-
31 ble:
32 (1) Fenfluramine.
33 (e) Stimulants. Unless specifically excepted or unless listed in another
34 schedule, any material, compound, mixture, or preparation which contains any
35 quantity of the following substances having a stimulant effect on the central
36 nervous system, including its salts, isomers (whether optical, position, or
37 geometric), and salts of such isomers whenever the existence of such salts,
38 isomers, and salts of isomers is possible within the specific chemical desig-
39 nation:
40 (1) Cathine ((+)-norpseudoephedrine);
41 (2) Diethylpropion;
42 (3) Fencamfamin;
43 (4) Fenproporex;
44 (5) Mazindol;
45 (6) Mefenorex;
46 (7) Pemoline (including organometallic complexes and chelates thereof);
47 (8) Phentermine;
48 (9) Pipradrol;
49 (10) Sibutramine;
50 (11) SPA ((-)-1-dimethylamino-1,2-diphenylethane).
51 (f) Other substances. Unless specifically excepted, or unless listed in
52 another schedule, any material, compound, mixture or preparation which con-
53 tains any quantity of the following substances, including its salts:
54 (1) Pentazocine;
55 (2) Carisoprodol.
3
1 (g) The board may except by rule any compound, mixture, or preparation
2 containing any depressant substance listed in subsection (c) of this section
3 from the application of all or any part of this act if the compound, mixture,
4 or preparation contains one (1) or more active medicinal ingredients not hav-
5 ing a depressant effect on the central nervous system, and if the admixtures
6 are included therein in combinations, quantity, proportion, or concentration
7 that vitiate the potential for abuse of the substances which have a depressant
8 effect on the central nervous system.
STATEMENT OF PURPOSE
RS 10662
The purpose of this proposed legislation is to add the drug
carisoprodol to Schedule IV of the controlled substance act
making it a felony to obtain this drug by misrepresentation,
fraud, forgery, deception or subterfuge. It would also restrict
prescriptions for this drug to five refills or six months and
automatically add it to our controlled substance tracking system.
This change is in response to the continued diversion and abuse
of this drug.
FISCAL IMPACT
There will be no fiscal on the General Fund, no cost to the
general public or practitioners, and implementation of
legislation will be from the Board of Pharmacy dedicated funds.
STATEMENT OF PURPOSE/FISCAL NOTE H 103
Contact
Name: Richard K. "Mick" Markuson, Executive Director
Idaho State Board of Pharmacy
Phone:
(208)334 2356
STATEMENT OF PURPOSE
RS 10759
To increase the grocery tax credit to $50.00 for the
calendar year 2001 and repeal sales tax on "food" beginning July
1, 2002. When sales tax is removed from food, the increased
grocery tax credit would be repealed. The definition for "food"
would be the same as for food stamps.
FISCAL IMPACT
Increasing the grocery tax credit would have projected
general fund impact of $18.6 Million for fiscal year 2002.
Subsequently repealing sales tax on "food" and repealing the
increased grocery tax credit would have a projected net general
fund impact of $84,908,808 in fiscal year 2003.
Contact
Name: Rep. Bill Sali
Phone:
332 1000
STATEMENT OF PURPOSE
RS 10748
To double the grocery tax credit for the calendar
and repeal sales tax on "food" beginning July 1, 2002.
sales tax is removed from food, the grocery tax credit
repealed. The definition for "food" would be the same food
stamps.
FISCAL
IMPACT
year 2001
When
would be
as for
Doubling the grocery tax credit would have projected general fund
impact of $18.6 Million for fiscal year 2002. Subsequently repealing
sales tax on "food" and repealing the increased grocery tax credit
would have a projected net general fund impact of $84,908,808 in fiscal
year 2003.
Contact
Name: Rep. Bill Sali
Phone: 332 1000